awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q44107109-4258CA13-DF22-451A-8A2A-DB79A85506BE
Q44107109-4258CA13-DF22-451A-8A2A-DB79A85506BE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44107109-4258CA13-DF22-451A-8A2A-DB79A85506BE
Fulvestrant 500 mg in postmenopausal patients with metastatic breast cancer: the initial clinical experience.
P2860
Q44107109-4258CA13-DF22-451A-8A2A-DB79A85506BE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44107109-4258CA13-DF22-451A-8A2A-DB79A85506BE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0d95df7c0ed2abbfd0ba165396e8356ce79f681e
P2860
Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer